vs
Side-by-side financial comparison of BioNTech SE (BNTX) and CACI INTERNATIONAL INC (CACI). Click either name above to swap in a different company.
CACI INTERNATIONAL INC is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× BioNTech SE). CACI INTERNATIONAL INC runs the higher net margin — 5.6% vs -1.9%, a 7.5% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
CACI International Inc is a U.S.-headquartered multinational professional services and information technology firm. It delivers custom technology solutions, cybersecurity services, data analytics, and mission-critical operational support to government defense, intelligence, civilian agencies, and select private sector clients.
BNTX vs CACI — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.2B |
| Net Profit | $-28.7M | $123.9M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | 9.3% |
| Net Margin | -1.9% | 5.6% |
| Revenue YoY | — | 5.7% |
| Net Profit YoY | — | 12.7% |
| EPS (diluted) | — | $5.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $260.8M | $2.3B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | — | $123.9M | ||
| Q3 25 | $-28.7M | $124.8M | ||
| Q2 25 | $-386.6M | $157.9M | ||
| Q1 25 | — | $111.9M | ||
| Q4 24 | — | $109.9M | ||
| Q3 24 | $198.1M | $120.2M | ||
| Q2 24 | — | $134.7M | ||
| Q1 24 | — | $115.3M |
| Q4 25 | — | 9.3% | ||
| Q3 25 | -3.1% | 9.3% | ||
| Q2 25 | -192.1% | 9.0% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | 0.8% | 8.7% | ||
| Q2 24 | — | 9.7% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | -1.9% | 5.5% | ||
| Q2 25 | -148.2% | 6.9% | ||
| Q1 25 | — | 5.2% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | 15.9% | 5.8% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 6.0% |
| Q4 25 | — | $5.59 | ||
| Q3 25 | — | $5.63 | ||
| Q2 25 | — | $7.11 | ||
| Q1 25 | — | $5.00 | ||
| Q4 24 | — | $4.88 | ||
| Q3 24 | — | $5.33 | ||
| Q2 24 | — | $5.97 | ||
| Q1 24 | — | $5.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $423.0M |
| Total DebtLower is stronger | — | $3.0B |
| Stockholders' EquityBook value | — | $4.1B |
| Total Assets | — | $8.9B |
| Debt / EquityLower = less leverage | — | 0.72× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $423.0M | ||
| Q3 25 | — | $133.0M | ||
| Q2 25 | — | $106.2M | ||
| Q1 25 | — | $223.9M | ||
| Q4 24 | — | $175.7M | ||
| Q3 24 | — | $440.7M | ||
| Q2 24 | — | $134.0M | ||
| Q1 24 | — | $159.2M |
| Q4 25 | — | $3.0B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $3.1B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | — | $4.1B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $3.7B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $3.4B |
| Q4 25 | — | $8.9B | ||
| Q3 25 | — | $8.7B | ||
| Q2 25 | — | $8.6B | ||
| Q1 25 | — | $8.6B | ||
| Q4 24 | — | $8.5B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $6.8B | ||
| Q1 24 | — | $6.8B |
| Q4 25 | — | 0.72× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 0.82× | ||
| Q3 24 | — | 0.50× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.50× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $154.2M |
| Free Cash FlowOCF − Capex | — | $138.2M |
| FCF MarginFCF / Revenue | — | 6.2% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | — | 1.24× |
| TTM Free Cash FlowTrailing 4 quarters | — | $634.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $154.2M | ||
| Q3 25 | — | $171.1M | ||
| Q2 25 | — | $156.0M | ||
| Q1 25 | — | $230.3M | ||
| Q4 24 | — | $126.0M | ||
| Q3 24 | — | $34.7M | ||
| Q2 24 | — | $157.2M | ||
| Q1 24 | — | $198.3M |
| Q4 25 | — | $138.2M | ||
| Q3 25 | — | $154.1M | ||
| Q2 25 | — | $128.0M | ||
| Q1 25 | — | $214.1M | ||
| Q4 24 | — | $116.1M | ||
| Q3 24 | — | $23.2M | ||
| Q2 24 | — | $134.6M | ||
| Q1 24 | — | $186.6M |
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 9.6% |
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 1.24× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 2.06× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 0.29× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | — | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNTX
Segment breakdown not available.
CACI
| Service Other | $876.3M | 39% |
| Intelligence Community | $539.0M | 24% |
| Federal Civilian Agencies | $438.6M | 20% |
| Subcontractor | $202.5M | 9% |
| Other | $148.5M | 7% |
| Commercial And Other | $15.2M | 1% |
